Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Total 13F shares
-
44,102,533
-
Share change
-
+5,283,948
-
Total reported value
-
$588,744,766
-
Put/Call ratio
-
41%
-
Price per share
-
$13.35
-
Number of holders
-
130
-
Value change
-
+$69,152,709
-
Number of buys
-
57
-
Number of sells
-
54
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q3 2019
As of 30 Sep 2019,
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,102,533 shares.
The largest 10 holders included
ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Atlas Venture Associates IX, LLC, Chevy Chase Trust Holdings, Inc., DIMENSIONAL FUND ADVISORS LP, and MORGAN STANLEY.
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.